IDO-IN-6

IDO-IN-6 (NLG-1486) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, Compound 1486, has an IC50 of <1 μM.

Indoleamine 2,3-Dioxygenase (IDO)

Reference compound

Metabolic Enzyme/Protease

Cancer-programmed cell death

Cancer

https://www.medchemexpress.com/IDO-IN-6.html

99.90

DMSO : 50 mg/mL (ultrasonic)

O[C@H](CC1)CC[C@]1([H])[C@@H](O)C[C@@H]2N3C(C4=C2C(F)=CC=C4)=CN=C3

316.37

[1]Mautino, et al. Preparation of fused imidazole derivatives as IDO inhibitors. From PCT Int. Appl. (2012), 20121018.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

http://file.medchemexpress.com/batch_PDF/HY-18770A/IDO-IN-6-DataSheet-MedChemExpress.pdf

http://file.medchemexpress.com/batch_PDF/HY-18770A/IDO-IN-6-SDS-MedChemExpress.pdf

No Development Reported

1402837-76-6